Medivir Appoints Yilmaz Mahshid as New CEO

STOCKHOLM, May 26, 2020 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that its Board of Directors has appointed Yilmaz Mahshid as the new CEO of the company. Yilmaz Mahshid has long and broad experience f... Biopharmaceuticals, Oncology, Personnel Medivir AB, hepatocellular carcinoma, liver cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news